New Studies Support Benefits of CRS/HIPEC Treatment in Peritoneal Mesothelioma, According to Surviving Mesothelioma
Raleigh, NC (PRWEB) April 27, 2016 -- Scientists in Lyon, France and British Columbia have released studies on the survival and quality of life benefits from the surgical procedure known as CRS with HIPEC. Surviving Mesothelioma has just posted the details on the website. Click here to read the full article.
The University of Lyon study focused on peritoneal cancer patients, including 84 with mesothelioma, treated with CRS/HIPEC since 1989.
“This study demonstrated that CRS and HIPEC provide long-term survival irrespective of PC [peritoneal cancer] origin, and survival improves with experience,” writes author and researcher Guillaume Passot, MD, in the Journal of Surgical Oncology.
A second study conducted by University of British Columbia researchers and published in the Annals of Surgical Oncology finds that even patients who have major complications after CRS/HIPEC tend to have a quality of life equal to the no-complication group in about 6 months.
“One of the most hopeful messages of these studies is that, the longer doctors perform CRS/HIPEC, the better the the outcomes for their patients seem to get. This should be reassuring for mesothelioma patients considering the procedure,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor.
For complete details of both new studies, see Specialized Mesothelioma Procedure Provides Long Survival, Good Life Quality, now available on the Surviving Mesothelioma website.
Passot, G, et al, “What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures”, April25, 2016, Journal of Surgical Oncology, Epud ahead of print, https://www.ncbi.nlm.nih.gov/pubmed/27110915
Hamilton, TD, et al, “Impact of Major Complications on Patients' Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy”, April 19, 2016, Annals of Surgical Oncology, Epub ahead of print, http://www.annsurgoncol.org/journals/abstract.html?v=0&j=10434&i=0&a=5231_10.1245_s10434-016-5231-2&doi=
Michael Ellis, Cancer Monthy, http://www.survivingmesothelioma.com, +1 (919) 570-8595, [email protected]
Share this article